Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

84.42
Delayed Data
As of Mar 23
 +0.06 / +0.07%
Today’s Change
64.18
Today|||52-Week Range
86.14
+14.78%
Year-to-Date
AstraZeneca Stock Rising in '17: What's Working in its Favor?
Mar 23 / Zacks.com - Paid Partner Content
Novartis (NVS) Announces Positive Data on Heart Failure Drug
Mar 20 / Zacks.com - Paid Partner Content
Merck Closes Acquisition of Controlling Stake in Vallee S.A
Mar 23 / Zacks.com - Paid Partner Content
European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details
Mar 20 / TheStreet.com - Paid Partner Content
Novartis' Acute Heart Failure Drug Fails in Late-Stage Study
Mar 22 / Zacks.com - Paid Partner Content
European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade
Mar 20 / TheStreet.com - Paid Partner Content
Harbour Capital Advisors, LLC Buys Amazon. ...
Mar 21 / GuruFocus News - Paid Partner Content
Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report
Mar 17 / TheStreet.com - Paid Partner Content
Lilly's Breast Cancer Combo Drug Phase III Results Positive
Mar 21 / Zacks.com - Paid Partner Content
Andreas Halvorsen Sells Amazon, MasterCard in 4th Quarter
Mar 17 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close84.36
Today’s open83.92
Day’s range83.92 - 85.05
Volume3,021,071
Average volume (3 months)5,420,238
Market cap$93.1B
Dividend yield2.46%
Data as of 03/23/2017

Growth & Valuation

Earnings growth (last year)+14.16%
Earnings growth (this year)+16.68%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+6.33%
P/E ratio32.7
Price/Sales3.68
Price/Book6.63

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.59-1.05%
CELGCelgene-0.15-0.12%
GSKGlaxoSmithKline+0.03+0.07%
ABBVAbbVie+0.13+0.20%
Data as of 03/23/2017

Financials

Next reporting dateApril 25, 2017
EPS forecast (this quarter)$0.96
Annual revenue (last year)$21.2B
Annual profit (last year)$2.7B
Net profit margin12.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
David A. Ricks
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts


Search for Jobs